Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report
Francesco Violi(Sapienza University of Rome), Francesco Pugliese(Sapienza University of Rome), Pasquale Pignatelli(Sapienza University of Rome), Gabriella d’Ettorre(Policlinico Umberto I), Francesco Alessandri(Sapienza University of Rome), Claudio Maria Mastroianni(Sapienza University of Rome), Giancarlo Ceccarelli(International Organization for Migration), Damiano D’Ardes(University of Chieti-Pescara), Lorenzo Loffredo(Sapienza University of Rome), Mario Venditti(Sapienza University of Rome), Francesco Cipollone(University of Chieti-Pescara)
Cited by 56
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351
The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide
|American Journal of Clinical Nutrition|2000|273
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
|International Journal of Environmental Research and Public Health|2021|272